targeted

Soft Space Enters into Strategic Partnership with JCB

Source Node:
Time Stamp: April 22, 2024 8:14 AM - Modified On: April 22, 2024 - Published By:
Source Cluster:
Republished By Plato

  Collaboration will expand JCB's presence in Southeast Asia and act as a bridge for Soft Space to link Japanese consumers with the region and vice versa KUALA LUMPUR & TOKYO, Jan 13, 2022 - (JCN Newswire) - The world's leading fintech player, Soft Space Sdn. Bhd. ("Soft Space"), has announced a new strategic partnership with Japan's only international payment brand, JCB Co. Ltd. ("JCB"). This strategic partnership is the first of its kind in Malaysia for the payment giant and involves a combination of US$5 million investment in Soft

Gain Therapeutics Achieves Remarkable Breakthrough in Parkinson’s Disease Research

Source Node:
Time Stamp: August 29, 2023 8:20 AM - Modified On: August 29, 2023 - Published By:
Source Cluster:
Republished By Plato

Gain Therapeutics, Inc. (Nasdaq: GANX), a pioneering biotechnology company specializing in innovative allosteric small molecule therapies, has made significant strides in the fight against Parkinson's disease (PD). The Company's lead drug candidate, GT-02287, has demonstrated extraordinary potential in mitigating the effects of Parkinson's disease across two distinct preclinical models of the ailment. These findings suggest that GT-02287 has the capacity to alleviate Parkinson's disease pathology and enhance motor function. A notable highlight is the substantial reduction of plasma Neurofilament Light Chain (NfL) levels, an emerging biomarker for neurodegeneration. This advancement

SCCG Partners with Kajot Games for Distribution of iGaming Content to North America and Worldwide

Source Node:
Time Stamp: August 9, 2023 8:47 AM - Modified On: August 9, 2023 - Published By:
Source Cluster:
Republished By Plato

Las Vegas, NV – SCCG Management, a leading advisory firm in the global gambling industry, is excited to announce a strategic partnership with Kajot, for the distribution of their world-class iGaming content, with an initial focus on social gaming in the United States. The collaboration is poised to eventually expand into real-money gaming within the US market, including targeted initiatives within specific states in collaboration with tribal casinos. Stephen Crystal, Founder & CEO of SCCG, stated, “We are thrilled to join forces with Kajot, an innovative partner known for their

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Source Node:
Time Stamp: June 7, 2023 12:22 PM - Modified On: June 7, 2023 - Published By:
Source Cluster:
Republished By Plato

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating